Analogous to CCR4, the upregulated KCNN4 expression is associated with adverse prognosis in numerous malignancies, including papillary thyroid carcinoma [37], pancreatic cancer [38], and ccRCC [39]. Here, KCNN4 is linked to pancreatic neoplasm.